1 / 15

Motivation and Impact of Prescription Drug Advertising on Consumers

This talk provides an overview of direct-to-consumer advertising (DTCA) of prescription drugs, including its evolution, trends, and effects on consumers. It also covers research on the content analysis of DTCA and its impact on consumer behavior.

petula
Download Presentation

Motivation and Impact of Prescription Drug Advertising on Consumers

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Consumers’ motivation in responding to prescription drug advertisingbyNithima Sumpradit, PhD1Frank J. Ascione, PharmD PhD2Richard P. Bagozzi, PhD3 1 Thai Food and Drug Administration 2 University of Michigan 3 Rice University

  2. Talk outline • Overview of direct-to-consumer advertising of prescription drugs (DTCA) • Evolution and Trends of DTCA • Effects of DTCA on consumers • Research about DTCA • Research 1: Content analysis of DTCA • Research 2: Impact of DTCA on consumers • Conclusions Motivation & DTCA-Slide 2- 04.01.04

  3. Evolution & Trends of DTCA • Philosophy in public policy regarding consumer protection • Self-care movement • Competition in drug market • Emergence: - Introduced in the USA, 1981 • - USFDA requested the 2-year moratorium, 1983-1985 • - USFDA issued the fair balance regulation for DTCA, 1985 • Trends: - Adopted in New Zealand • - Debated in Canada and EU • - Placed concerns in developing countries Motivation & DTCA-Slide 3- 04.01.04

  4. Types & Regulations of DTCA Motivation & DTC advertising-Slide 4- 04.01.04

  5. Effects of DTCA Motivation & DTC advertising-Slide 5- 04.01.04

  6. Research • Research 1: Content analysis of DTCA characteristics • Sumpradit N, Ascione FJ, Bagozzi RP. A cross-media content analysis of motivational themes in direct-to-consumer prescription drug advertising.Clinical Therapeutics. 2004; 26(1): 135-154. • Research 2: Impact of DTCA on consumer behavior • Sumpradit N, Ascione FJ, Bagozzi RP. “Give me happiness versus take away our pain”: Consumers’ motivation in responding to prescription drug advertising. (working manuscript) Motivation & DTC advertising-Slide 6- 04.01.04

  7. Research 1: Content Analysis of DTCA • Goal: To examine motivational strategies used in DTCA • Method: • Analyses of ads presented in 10 consumer magazines and 4 TV channel networks during Sep–Dec 2001 • Two drug classes • Cox-2 inhibitors (Celebrex® vs. Vioxx®) • Statin drugs (Lipitor®, Pravachol®, vs. Zocor®) • Three independent trained judges Motivation & DTC advertising-Slide 7- 04.01.04

  8. Research 1(Results) • Cultural orientation • Use motivational themes that are consistent with cultural values. • Ex. US ads rely on individualistic (as opposed to collectivistic) orientation. • Goal orientation • Maximize the promise of obtaining positive outcomes • Minimized the chance that negative outcomes would occur • Presentation style  Cognition • Maximize association between product and positive attributes • Ex. Direct match of visual-verbal presentation in the benefit information announcement • Minimize association between product and negative attributes. • Ex. No visual-verbal match in the risk information announcement Motivation & DTC advertising-Slide 8- 04.01.04

  9. Research 2 • Cultural orientation • Use motivational themes that are consistent with cultural values. • Ex. US ads rely on individualistic (as opposed to collectivistic) orientation. • Goal orientation • Maximize the promise of obtaining positive outcomes • Minimized the chance that negative outcomes would occur • Presentation style  Cognition • Maximize association between product and positive attributes • Ex. Direct match of visual-verbal presentation in the benefit information announcement • Minimize association between product and negative attributes. • Ex. No visual-verbal match in the risk information announcement Objective 1: How can the motivational themes persuade consumers to take actions? Objective 2: How can the motivational themes affect consumers’ ability to recall of risk information? Motivation & DTC advertising-Slide 9- 04.01.04

  10. Goal compatibility • Goal compatibility occurs when the ad combines: • Promotion focus with Independent self • Prevention focus with Interdependent self Motivation & DTC advertising-Slide 8- 08.15.03 Motivation & DTC advertising-Slide 10- 04.01.04

  11. Research 2 (Methodology) • Methods: • Design: Experiment based on a 2 (promotion vs. prevention) x 2 (independence vs. interdependence) factorial design • Sample: 220 females aged 40 years old or older • Data collection procedures: They were randomly assigned to view one of the four mock ads for cholesterol-lowering drug (Travacor) and completed a questionnaire. • Data analyses: Two-way ANOVA/ANCOVA Motivation & DTC advertising-Slide 11- 04.01.04

  12. Research 2 (Persuasive effects of DTCA) Intention to talk about high cholesterol with doctor (1 = definitely not to talk to 5 = definitely yes to talk with MD) Positive/Neutral DTCA attitude Negative DTCA attitude B D A C B C A D Motivation & DTC advertising-Slide 13- 04.01.04

  13. Research 2 (Effects on risk info recall) Motivation & DTC advertising-Slide 21- 08.15.03 Motivation & DTC advertising-Slide 14- 04.01.04 Motivation & DTC advertising-Slide 14- 03.27.04

  14. Conclusions In Thailand, we prohibit prescription drugs to be advertised directly to consumers. So, why worry? • Failure of the drug distribution system (i.e., Rx drugs are accessible just like OTC drugs) remains unresolved. • Technology makes the world smaller. • DTCA is already here whether we are ready or not! Motivation & DTC advertising-Slide 15- 04.01.04

  15. Definitely shrunk if it’s a counterfeit drug. For questions about impotence diseases, please call 0-2664-5888 [Insert Logos] Pfizer – an expert in research and development for pharmaceuticals for sexual impotence diseases Source: Home & Lady, August 2546

More Related